THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is your one-stop reference to make investment decisions, pitch to potential partners, or estimate the value of an R&D program.
- Bruce Booth, Partner, Atlas Venture
Download a free sample chapter: Projecting Market Share for R&D-Stage Biotechs
Read the table of contents and get more details here
Many early-stage drug development projects don't progress if the team is stretched thin, and people and resources are focused on more advanced assets.
To fully realize the value of projects under development, these companies need external support that is both senior-level and hands-on.
Pharmagellan offers just that: expert advice and project execution to biotech and pharma companies willing to discover how far they can go. Learn more about what we do and how we can help.
Preclinical, translational, and early clinical strategy and execution
Competitive and financial analysis of products, portfolios, and companies